SCHEMBL264011

SCHEMBL264011

COC(=O)N(N)C(=N)CCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9275602 0.94
SCHEMBL7904856 0.79
SCHEMBL9076139 0.79 CA14 (0.33)
SCHEMBL2811802 0.76
SCHEMBL7778538 0.74 ALDH1A1 (0.39)
SCHEMBL8544000 0.69
SCHEMBL27833678 0.67
SCHEMBL11781368 0.67
SCHEMBL27995532 0.67 ALOX15 (0.33)
SCHEMBL28867334 0.64 CTSD (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8080656-B2 Process for the preparation of aprepitant RANBAXY LABORATORIES LIMITED (IN) 2011-12-20 US claimed
WO-2009116081-A2 AN IMPROVED PROCESS FOR THE PREPARATION OF APREPITANT MSN LABORATORIES LIMITED (IN) 2009-09-24 WO claimed
US-5637699-A CARDIOVASCULAR DISORDERS; ANTIINFLAMMATORY AGENT MERCK & CO., INC. (US) 1997-06-10 US claimed
US-6432953-B1 None US disclosed
EP-2817305-B1 AN IMPROVED PROCESS FOR THE PREPARATION OF APREPITANT PIRAMAL ENTPR LTD (IN) 2016-09-28 EP disclosed
US-20160031867-A1 AN IMPROVED PROCESS FOR THE PREPARATION OF APREPITANT Piramal Enterprises Limited (IN) 2016-02-04 US disclosed
EP-2817305-A1 AN IMPROVED PROCESS FOR THE PREPARATION OF APREPITANT Piramal Enterprises Limited (IN) 2014-12-31 EP disclosed
WO-2013124823-A1 AN IMPROVED PROCESS FOR THE PREPARATION OF APREPITANT Piramal Enterprises Limited (IN) 2013-08-29 WO disclosed
US-8133994-B2 Preparation of aprepitant DR. REDDY'S LABORATORIES LTD. (IN) 2012-03-13 US disclosed
US-20110094321-A1 PREPARATION OF APREPITANT DR. REDDY'S LABORATORIES LIMITED (IN) 2011-04-28 US disclosed
EP-1394150-B1 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists HOFFMANN LA ROCHE (CH) 2011-01-19 EP disclosed
WO-1995016679-A1 MORPHOLINE AND THIOMORPHOLINE TACHYKININ RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1995-06-22 WO disclosed
EP-0652866-A1 AZACYCLIC COMPOUNDS MERCK SHARP &amp; DOHME LTD. (GB) 1995-05-17 EP disclosed
EP-0636130-A1 AZACYCLIC COMPOUNDS MERCK SHARP & DOHME LTD. (GB) 1995-02-01 EP disclosed
WO-1994019323-A1 AZACYCLIC COMPOUNDS, COMPOSITIONS CONTAINING THEM AND THEIR USE AS TACHYKININ ANTAGONISTS MERCK SHARP & DOHME LIMITED (GB) 1994-09-01 WO disclosed
WO-1994002461-A1 AZACYCLIC COMPOUNDS MERCK SHARP & DOHME LIMITED (GB) 1994-02-03 WO disclosed
WO-1994000440-A1 MORPHOLINE AND THIOMORPHOLINE TACHYKININ RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1994-01-06 WO disclosed
EP-0577394-A1 Morpholine and thiomorpholine tachykinin receptor antagonists MERCK & CO. INC. (US) 1994-01-05 EP disclosed
WO-1993024465-A1 2/3-(HETEROCYCLIC ALKYL AMINO)-1-(SUBST.-PHENYL-METHOXY)-ETHANES/PROPANES AS TACHYKININ-RECEPTOR ANTAGONISTS MERCK SHARP & DOHME LIMITED (GB) 1993-12-09 WO disclosed
WO-1993021181-A1 AZACYCLIC COMPOUNDS MERCK SHARP & DOHME LIMITED (GB) 1993-10-28 WO disclosed